From: Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Primary cancer | No of specimens | NIS mRNA | NIS protein positive (%) | References |
---|---|---|---|---|
Bladder | 24 | n.d. | 42 | [13] |
Cervix | 11 | n.d. | 100 | [13] |
Colon | 75 | n.d. | 63 | [13] |
Esophagus | 15 | n.d. | 47 | [13] |
 | 20 | n.d. | 20 | [13] |
Liver | 26 | + | 8 | [74] |
 | 20* | + | 100 | [74] |
Lung | 58 | n.d. | 66 | [13] |
Ovary | 37 | n.d. | 73 | [13] |
Pancreas | 11 | n.d. | 64 | [13] |
Prostate | 34 | n.d. | 74 | [13] |
Skin squamous | 18 | n.d. | 56 | [13] |
Stomach | 27 | n.d. | 59 | [13] |
 | 4 | + | n.d. | [12] |
Submandibular gland | 3 | + | n.d. | [12] |
Testis | 11 | n.d. | 9 | [13] |
 | 107 | + | 64 | [75] |
Uterus endometrium | 25 | n.d. | 56 | [13] |
Metastatic cancer | Â | Â | Â | Â |
Liver** | 15 | n.d. | 80 | [76] |
Brain*** | 28 | n.d. | 84 | [40] |